Eagle Asset Management Inc Astrazeneca PLC Transaction History

Eagle Asset Management Inc

$16.7 Billion
Q3 2024

A detailed history of Eagle Asset Management Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Eagle Asset Management Inc holds 575,604 shares of AZN stock, worth $42.7 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

575,604

Previous 1,420,183 59.47%

Holding current value

$42.7 Million

Previous $111 Million 59.51%

% of portfolio

0.27%

Previous 0.61%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $64.8 Million - $74 Million	-844,579 Reduced 59.47%	575,604 $44.9 Million
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $714,399 - $864,315	-10,693 Reduced 0.75%	1,420,183 $111 Million
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $5.06 Million - $5.77 Million	82,911 Added 6.15%	1,430,876 $96.9 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $36.9 Million - $41.4 Million	-597,005 Reduced 30.69%	1,347,965 $90.8 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $22.8 Million - $25.2 Million	351,479 Added 22.06%	1,944,970 $132 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $4.17 Million - $4.52 Million	-59,587 Reduced 3.6%	1,593,491 $114 Million
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $810,403 - $918,842	-12,833 Reduced 0.77%	1,653,078 $115 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $7.59 Million - $9.86 Million	-139,958 Reduced 7.75%	1,665,911 $113 Million
Q3 2022 Nov 07, 2022	BUY	$53.02 - $135.75 $8.48 Million - $21.7 Million	159,869 Added 9.71%	1,805,869 $99 Million
Q2 2022 Aug 10, 2022	BUY	$59.26 - $71.14 $146,075 - $175,360	2,465 Added 0.15%	1,646,000 $109 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $9.47 Million - $11.4 Million	169,898 Added 11.53%	1,643,535 $109 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $701,665 - $829,087	-12,989 Reduced 0.87%	1,473,637 $86.2 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $81.8 Million - $89.5 Million	1,471,500 Added 9728.28%	1,486,626 $89.3 Million
Q2 2021 Aug 11, 2021	BUY	$48.42 - $60.18 $55,344 - $68,785	1,143 Added 8.17%	15,126 $906,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $433,541 - $500,466	9,193 Added 191.92%	13,983 $692,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $417,126 - $498,797	-8,597 Reduced 64.22%	4,790 $239,000
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $30,727 - $35,376	-579 Reduced 4.15%	13,387 $737,000
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $601,934 - $772,459	13,966 New	13,966 $738,000

Others Institutions Holding AZN

# of Institutions

1,356

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $230B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Account

Eagle Asset Management Inc Astrazeneca PLC Transaction History